David N Gill - Net Worth and Insider Trading
David N Gill Net Worth
The estimated net worth of David N Gill is at least $2 Million dollars as of 2024-04-26. David N Gill is the CFO of EndoChoice Holdings Inc and owns about 149,204 shares of EndoChoice Holdings Inc (GI) stock worth over $1 Million. David N Gill is the Director of Evolus Inc and owns about 29,568 shares of Evolus Inc (EOLS) stock worth over $338,849. David N Gill is also the Director of Strongbridge Biopharma PLC and owns about 74,896 shares of Strongbridge Biopharma PLC (SBBP) stock worth over $149,792. Besides these, David N Gill also holds Ocugen Inc (OCGN) , Melinta Therapeutics Inc (MLNTQ) , Y-mAbs Therapeutics Inc (YMAB) . Details can be seen in David N Gill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David N Gill has not made any transactions after 2022-05-16 and currently still holds the listed stock(s).
Transaction Summary of David N Gill
David N Gill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David N Gill owns 9 companies in total, including Strongbridge Biopharma PLC (SBBP) , Y-mAbs Therapeutics Inc (YMAB) , and Evolus Inc (EOLS) among others .
Click here to see the complete history of David N Gill’s form 4 insider trades.
Insider Ownership Summary of David N Gill
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SBBP | Strongbridge Biopharma PLC | 2020-09-24 | director |
YMAB | Y-mAbs Therapeutics Inc | 2021-01-19 | director |
EOLS | Evolus Inc | 2022-05-16 | director |
SSKN | Strata Skin Sciences Inc | 2019-11-22 | director |
MLNTQ | Melinta Therapeutics Inc | 2019-06-11 | director |
OCGN | Ocugen Inc | 2017-08-16 | director |
GI | EndoChoice Holdings Inc | 2016-11-22 | President and CFO |
LMAT | LeMaitre Vascular Inc | 2006-10-18 | director |
NXTM | NxStage Medical Inc | 2006-05-10 | SVP & CFO |
David N Gill Latest Holdings Summary
David N Gill currently owns a total of 6 stocks. Among these stocks, David N Gill owns 149,204 shares of EndoChoice Holdings Inc (GI) as of March 10, 2016, with a value of $1 Million and a weighting of 70.94%. David N Gill owns 29,568 shares of Evolus Inc (EOLS) as of May 16, 2022, with a value of $338,849 and a weighting of 20.14%. David N Gill also owns 74,896 shares of Strongbridge Biopharma PLC (SBBP) as of September 24, 2020, with a value of $149,792 and a weighting of 8.9%. The other 3 stocks Ocugen Inc (OCGN) , Melinta Therapeutics Inc (MLNTQ) , Y-mAbs Therapeutics Inc (YMAB) have a combined weighting of 0.02% among all his current holdings.
Latest Holdings of David N Gill
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GI | EndoChoice Holdings Inc | 2016-03-10 | 149,204 | 8.00 | 1,193,632 |
EOLS | Evolus Inc | 2022-05-16 | 29,568 | 11.46 | 338,849 |
SBBP | Strongbridge Biopharma PLC | 2020-09-24 | 74,896 | 2.00 | 149,792 |
OCGN | Ocugen Inc | 2017-08-16 | 233 | 1.18 | 275 |
MLNTQ | Melinta Therapeutics Inc | 2018-05-25 | 1,200 | 0.11 | 132 |
YMAB | Y-mAbs Therapeutics Inc | 2021-01-19 | 0 | 14.84 | 0 |
Holding Weightings of David N Gill
David N Gill Form 4 Trading Tracker
According to the SEC Form 4 filings, David N Gill has made a total of 0 transactions in EndoChoice Holdings Inc (GI) over the past 5 years. The most-recent trade in EndoChoice Holdings Inc is the acquisition of 2,000 shares on March 10, 2016, which cost David N Gill around $9,400.
According to the SEC Form 4 filings, David N Gill has made a total of 2 transactions in Evolus Inc (EOLS) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Evolus Inc is the sale of 10,313 shares on May 16, 2022, which brought David N Gill around $137,679.
According to the SEC Form 4 filings, David N Gill has made a total of 1 transactions in Strongbridge Biopharma PLC (SBBP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Strongbridge Biopharma PLC is the acquisition of 8,000 shares on September 24, 2020, which cost David N Gill around $17,040.
More details on David N Gill's insider transactions can be found in the Insider Trading History of David N Gill table.Insider Trading History of David N Gill
- 1
David N Gill Trading Performance
GuruFocus tracks the stock performance after each of David N Gill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David N Gill is 10.7%. GuruFocus also compares David N Gill's trading performance to market benchmark return within the same time period. The performance of stocks bought by David N Gill within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David N Gill's insider trading performs compared to the benchmark.
Performance of David N Gill
Average Return
-8.12%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 6.2 | 10.7 | 0.59 | -8.12 | -45.99 | -61.22 |
Relative Return to S&P 500(%) | 4.33 | 4.67 | -8.1 | -24.66 | -58.07 | -73.01 |
David N Gill Ownership Network
Ownership Network List of David N Gill
Ownership Network Relation of David N Gill
David N Gill Owned Company Details
What does Strongbridge Biopharma PLC do?
Who are the key executives at Strongbridge Biopharma PLC?
David N Gill is the director of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Cdk Associates, L.l.c. , 10 percent owner Caxton Corp , and 10 percent owner Bruce Kovner .
Strongbridge Biopharma PLC (SBBP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Strongbridge Biopharma PLC Insider Transactions
David N Gill Mailing Address
Above is the net worth, insider trading, and ownership report for David N Gill. You might contact David N Gill via mailing address: C/o Nxstage Medical Inc. (nxtm), 439 South Union Street, 5th Floor, Lawrence Ma 01843.